Irska - engleski - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 30 milligram - 06ba12

Irska - engleski - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 70 milligram - 06ba12

Irska - engleski - HPRA (Health Products Regulatory Authority)

shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 50 milligram - 06ba12

Malta - engleski - Medicines Authority

alliance pharmaceuticals limited - ascorbic acid; sodium ascorbate - chewable tablet - ascorbic acid 148.93 mg; sodium ascorbate 176.74 mg - vitamins

Malta - engleski - Medicines Authority

alliance pharmaceuticals limited - paracetamol; phenylephrine hydrochloride; caffeine; diphenhydramine hydrochloride; codeine phosphate - film-coated tablet - paracetamol 500 mg; phenylephrine hydrochloride 10 mg; caffeine 30 mg; diphenhydramine hydrochloride 15 mg; codeine phosphate 10 mg - cough and cold preparations

Irska - engleski - HPRA (Health Products Regulatory Authority)

teva pharmaceuticals limited - glatiramer acetate - solution for injection - 40 mg/ml - other immunostimulants - antineoplastic and immunomodulating agents, immunostimulants - it is indicated for the treatment of relapsing forms of multiple sclerosis (ms) (see section 5.1 for important information on the population for which efficacy has been established). copaxone is not indicated in primary or secondary progressive ms.

Velika Britanija - engleski - myHealthbox

claris lifesciences uk limited - zoledronic acid - concentrate for solution for infusion - 4mg/5ml - drugs for treatment of bone diseases, bisphosphonates - prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone. treatment of adult patients with tumour-induced hypercalcaemia (tih)

Europska Unija - engleski - EMA (European Medicines Agency)

shire pharmaceutical contracts limited - epoetin delta - kidney failure, chronic; anemia - antianemic preparations - dynepo is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult patients. it may be used in patients on dialysis and in patients not on dialysis.

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - hydroxyzine hydrochloride - oral tablet - 10mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - hydroxyzine hydrochloride - oral tablet - 25mg